Yellow Eyelid Growths (Xanthelasma) Treatment | IC Clinic
“I have a yellow growth on my eyelid — could it be xanthelasma?”
“What should I do about symptoms that look like xanthelasma?”
“Is the treatment painful?”
Do you have questions about growths around your eyes?
Several skin conditions can cause growths on the skin’s surface, but a yellow growth on the eyelid is likely to be xanthelasma palpebrarum.
On this page, we focus on xanthelasma palpebrarum — the most common form of xanthoma — and explain its symptoms and causes. Because xanthelasma is difficult to improve with self-care alone, please consider consulting a clinic.
What Is Xanthoma? Yellowish Growths That Often Appear on the Eyelids
Xanthomas are named differently depending on where they develop on the body.
Among them, xanthelasma palpebrarum — which forms on the eyelids — is particularly common. Below, we explain the symptoms and causes of xanthelasma palpebrarum.
Symptoms of Xanthelasma Palpebrarum
Xanthelasma palpebrarum is a benign growth that typically develops on the eyelids, especially on the inner upper eyelid. The affected area appears yellowish and slightly raised.
Growths associated with xanthelasma palpebrarum range from approximately 3 mm for smaller lesions to several centimetres for larger ones. The affected area is not painful or itchy.
Because the eyelids are difficult to conceal with a mask or other coverings, many patients seek removal of xanthelasma palpebrarum due to cosmetic concerns.
Causes of Xanthelasma Palpebrarum
Xanthomas themselves are caused by LDL cholesterol (lipids), and tend to develop in people with dyslipidaemia or hyperlipidaemia.
Cells that have absorbed lipids penetrate the dermis (the deeper layer of the skin), leading to the development of xanthoma.
Xanthelasma palpebrarum tends to develop in people with hyperlipidaemia — a condition in which excess fat accumulates in the blood. However, not everyone who develops xanthelasma palpebrarum has hyperlipidaemia.
It is thought that external stimuli and inflammation, in addition to internal lipid levels, can increase blood lipids and contribute to the development of xanthelasma palpebrarum.
Xanthelasma Palpebrarum Treatment at IC Clinic
Our clinic offers the following two treatment options for xanthelasma palpebrarum:
- Surgery
- CO2 (Carbon Dioxide) Laser
Below, we explain the features and benefits of each treatment option.
Surgery
Surgical treatment allows for the removal of xanthelasma palpebrarum.
During surgery, the affected area is excised in a spindle shape and sutured along the double-eyelid crease. Care is taken to avoid disrupting the double-eyelid line as a result of the excision.
Since the skin of the upper eyelid has a relatively generous amount of laxity, it is possible to excise up to approximately half of the eyelid. In patients with eyelid sagging, a wider incision that includes the excess skin may be made.
It is also worth noting that xanthelasma palpebrarum may recur after surgery. If there is insufficient eyelid skin laxity to allow reoperation, other treatment options may be required.
At our clinic, surgeries are performed by physicians with extensive knowledge and experience, so please consider this as a treatment option for xanthelasma palpebrarum.
CO2 (Carbon Dioxide) Laser
CO2 laser treatment is a method that uses laser irradiation to remove xanthelasma palpebrarum.
Compared with surgery, it offers the advantages of a shorter treatment time and a lower likelihood of visible scarring.
This is because the surrounding skin is minimally affected and the dermis — the deeper layer of the skin — is preserved during treatment.
While laser irradiation on the surface inevitably causes some damage to blood vessels, the thermal coagulation effect causes vessels to seal almost immediately. As a result, bleeding during treatment is minimal.
For more details about our CO2 laser treatment, please visit the page below.
Wart and Mole Removal with CO2 (Carbon Dioxide) Laser | Features, Pricing, and Important Points
Frequently Asked Questions About Xanthoma
Here we answer frequently asked questions about xanthoma.
Even if left untreated, xanthelasma palpebrarum will not resolve on its own.
Therefore, treatment is necessary to remove xanthelasma palpebrarum.
Because xanthelasma palpebrarum develops in a visible area that cannot be concealed with clothing or a mask, anyone concerned about its appearance should consult a dermatologist at an early stage. If left untreated, the affected area may gradually enlarge.
Our clinic performs excision surgery covered by health insurance. Depending on the condition, CO2 laser treatment may also be an option, so please feel free to contact us for a consultation.
Surgery for xanthelasma palpebrarum is eligible for health insurance coverage.
Insurance also applies to costs beyond the surgery itself, such as diagnosis and examination.
However, CO2 laser treatment is not covered by health insurance.
The appropriate treatment method varies depending on the condition of the affected area, so please ask about the details of treatment costs at the time of your consultation.
Surgical incision does leave a scar at the excision site.
With CO2 laser treatment, the dermis — the deeper layer of the skin — is preserved, which reduces the likelihood of visible scarring.
At our clinic, we take care to minimise scarring even when surgical incision is performed. We will address your concerns and adapt our approach to meet your wishes, so if you are worried about the appearance of the treated area after treatment, please feel free to contact us for a consultation.
Prescribing oral medication to manage hyperlipidaemia is one treatment option for patients with xanthoma.
However, as results may not always be noticeable, surgical treatment or CO2 laser treatment may allow for more effective management of symptoms. In addition, oral medication typically needs to be taken over an extended period.
If you have any questions or preferences regarding oral medication, please let us know at the time of your consultation.
Juvenile xanthogranuloma, one of the conditions in the xanthoma group, can develop in infants.
Juvenile xanthogranuloma may be present from birth or symptoms may appear within the first few months of life. However, symptoms often improve naturally by the age of 3 to 6 years.
Granulomas that develop in the affected area range from a few millimetres to approximately 1 cm in size, and commonly appear on the head and face.
Please note that our clinic does not provide treatment for patients aged 12 or under. If we receive an enquiry regarding symptoms in an infant or a child aged 12 or under, we will provide a referral to a general hospital or equivalent facility.
Consult IC Clinic for Xanthelasma Palpebrarum Treatment
Although xanthelasma palpebrarum tends to develop in people with hyperlipidaemia, it is a skin condition that can affect anyone.
Because it will not resolve on its own if left untreated, please seek a medical consultation.
IC Clinic strives to be a welcoming clinic where patients of all ages and backgrounds feel comfortable seeking advice.
Whatever your symptoms, we will work together with you to suggest an appropriate treatment plan — so if you have any concerns about growths around the eyelid area, please do not hesitate to consult IC Clinic.
Features of Xanthoma Treatment at IC Clinic
At IC Clinic, our approach to xanthoma treatment is characterised by the following features.
Specialist Expertise in Xanthelasma Palpebrarum Treatment We have extensive experience treating this delicate area around the eyes, with a clinical record of several hundred xanthelasma palpebrarum cases per year. We propose a treatment approach tailored to each individual patient, taking both cosmetic and functional considerations into account.
Coordination with Internal Medicine Because xanthoma is closely associated with hyperlipidaemia, we coordinate with internal medicine as needed to provide comprehensive care that addresses underlying lifestyle factors.
Treatment Strategy with Recurrence in Mind As xanthelasma palpebrarum carries a risk of recurrence, we develop a treatment plan aimed at minimising recurrence — from the selection of the initial treatment method through to long-term follow-up.
Detailed Classification and Diagnosis of Xanthoma
Xanthelasma Palpebrarum (Xanthelasma palpebrarum)
Location: Upper and lower eyelids, particularly the medial canthal area Characteristics: Flat or slightly raised, yellowish-white, well-defined borders Association with hyperlipidaemia: Abnormal blood lipid levels are observed in 50–60% of cases
Nodular Xanthoma (Nodular xanthoma)
Location: Elbows, knees, finger joints Characteristics: Nodular elevation, diameter ranging from a few mm to several cm Association with hyperlipidaemia: Severe dyslipidaemia is present in more than 90% of cases
Tendon Xanthoma (Tendon xanthoma)
Location: Achilles tendon, extensor tendons of the fingers Characteristics: Hard mass along the tendon Association with hyperlipidaemia: Characteristic of familial hypercholesterolaemia
Palmar Xanthoma (Palmar xanthoma)
Location: Palms, linear creases of the fingers Characteristics: Yellow-orange linear lesions Association with hyperlipidaemia: Specific to type III hyperlipidaemia
Treatment Process
1. Initial Consultation and Detailed Diagnosis
- Medical history taking and family history review
- Detailed examination using a dermatoscope
- Differential diagnosis from other conditions (syringoma, milia, etc.)
- Blood test order (lipid profile)
- Detailed explanation of the treatment plan
2. Treatment Planning
- Assessment of lesion size, number, and location
- Patient preferences (cosmetic priority vs. functional priority)
- Downtime adjustment based on lifestyle
- Selection of treatment method with recurrence risk in mind
3. Treatment and Follow-up
- Procedure using the selected treatment method
- Post-treatment care guidance and regular follow-up
- Ongoing guidance for hyperlipidaemia management
Detailed Comparison of Treatment Options and Selection Criteria
Surgical Treatment
Indications
- Lesion size: 5 mm or larger
- Thicker lesions
- When complete removal is desired
- When health insurance coverage is preferred
Surgical Procedure
- Local anaesthesia (lidocaine + epinephrine)
- Spindle-shaped incision (along the double-eyelid crease)
- Complete excision of the lesion
- Layered closure (3-0 absorbable sutures + 6-0 nylon sutures)
- Post-operative gauze dressing
Advantages and Disadvantages
- ✓ Covered by health insurance, reducing out-of-pocket costs
- ✓ Lower recurrence rate due to complete removal
- ✓ Allows for histological examination
- ✗ Leaves a linear scar
- ✗ Downtime of 1–2 weeks
CO2 (Carbon Dioxide) Laser Treatment
Indications
- Lesion size: smaller than 10 mm
- Flat or mildly raised lesions
- When minimising scarring is a priority
- Treatment of multiple lesions in a single session
Treatment Procedure
- Topical anaesthesia (local anaesthesia added if necessary)
- Laser irradiation (gradual ablation with adjusted output settings)
- Cooling treatment
- Wound protection
Advantages and Disadvantages
- ✓ Minimal scarring
- ✓ Short treatment time (10–20 minutes)
- ✓ Multiple lesions can be treated in a single visit
- ✗ Not covered by health insurance; higher out-of-pocket cost
- ✗ Complete removal may not always be achievable
Aftercare and Post-Treatment Management
Post-Surgical Recovery
- Day of surgery to day 3: Peak swelling and mild discomfort
- Days 3–7 post-surgery: Suture removal and progress check
- 1–2 weeks post-surgery: Reduction in redness
- 1–3 months post-surgery: Scar maturation
- 6 months to 1 year post-surgery: Final appearance
Post-Laser Recovery
- Day of treatment: Mild redness and swelling
- 3–5 days post-treatment: Crust formation
- 1–2 weeks post-treatment: Crust falls off, new skin regenerates
- 1 month post-treatment: Near-complete healing
Post-Treatment Care Guidance
- Infection Prevention
- Proper use of prescribed ointment
- Handling the wound with clean hands
- Avoiding use of unsuitable cosmetics
- Scar Care
- Thorough sun protection
- Continued moisturising care
- Massage to soften the scar
- Recurrence Prevention
- Ongoing management of hyperlipidaemia
- Regular blood tests
- Continued improvement of lifestyle habits
Management of Hyperlipidaemia and Prevention
Reference Values for Dyslipidaemia
- LDL cholesterol: abnormal at 140 mg/dL or above
- HDL cholesterol: abnormal at below 40 mg/dL
- Triglycerides: abnormal at 150 mg/dL or above
- Total cholesterol: attention warranted at 220 mg/dL or above
Lifestyle Modification Guidance
- Dietary Therapy
- Limiting saturated fat intake (meat, dairy products)
- Increasing unsaturated fat intake (fish, vegetable oils)
- Actively consuming fibre-rich foods
- Moderating alcohol consumption
- Exercise Therapy
- Aerobic exercise: at least 3 times per week, 30 minutes or more per session
- Strength training: 2–3 times per week
- Increasing daily physical activity levels
Pharmacotherapy (in Coordination with Internal Medicine)
- Statin Medications
- Atorvastatin, rosuvastatin, etc.
- LDL cholesterol-lowering effect
- Fibrate Medications
- Bezafibrate, fenofibrate, etc.
- Triglyceride-lowering effect
- Other Medications
- Ezetimibe: cholesterol absorption inhibitor
- Nicotinic acid derivatives: HDL-raising effect
Differential Diagnosis from Other Eyelid Conditions
Differentiating from Syringoma
Key Distinguishing Features
- Syringoma: skin-coloured to light pinkish, multiple lesions, 1–3 mm
- Xanthelasma: yellowish-white, single to few lesions, 3 mm or larger
Confirmatory Diagnosis
- Comparison of dermatoscopic findings
- Skin biopsy if necessary
Differentiating from Milia
Key Distinguishing Features
- Milia: white, firm, 1–2 mm
- Xanthelasma: yellow, soft, flat
Differentiating from Sebaceous Hyperplasia
Key Distinguishing Features
- Sebaceous hyperplasia: central umbilication, commonly found on the nose and forehead
- Xanthelasma: flat or raised, commonly found on the eyelids
Differentiating from Basal Cell Carcinoma
Key Distinguishing Features
- Basal cell carcinoma: pearly lustre, visible blood vessels, ulceration
- Xanthelasma: yellowish hue, smooth surface, symmetrical appearance
Recurrence Prevention and Long-Term Follow-Up
Causes of Recurrence
- Incomplete removal (more common with laser treatment)
- Inadequate management of hyperlipidaemia
- Genetic factors
- Age-related metabolic changes
Recurrence Prevention Strategy
- Appropriate Selection of Treatment Method
- Prioritising surgery for larger lesions
- Emphasis on complete removal at the time of initial treatment
- Ongoing Internal Medicine Management
- Blood tests every 3–6 months
- Improving adherence to pharmacotherapy
- Continued improvement of lifestyle habits
- Regular Dermatology Appointments
- Follow-up every 6 months
- Early detection of new lesions
- Monitoring the condition of treated areas
